天堂网亚洲,天天操天天搞,91视频高清,菠萝蜜视频在线观看入口,美女视频性感美女视频,95丝袜美女视频国产,超高清美女视频图片

ChemicalBook
Chinese English Germany Korean

企業(yè)の連絡(luò)先情報(bào)

名前:
電話番號(hào):-
電子メール:sangon@qq.com
國(guó)籍:CHINA
ウェブサイト:www.sangon.com
商品の合計(jì)數(shù):47239
213 214 215 216 217 218 219 220 221 222 223 224 225 226 227 228 229 230 231 232 233 234 235 236 237 238 239 240 241 242 243 244 245 246 247 248 249 250 251 252 253 254 255 256 257 258 259 260 261 262 263 264 265 266 267 268 269 270 271 272 273 274 275 276 277 278 279 280 281 282 283 284 285 286 287 288 289 290 291 292 293 294 295 296 297 298 299 300 301 302 303 304 305 306 307 308 309 310 311 312 313 314 315 316 317

製品カタログ

N-((4,6-dimethyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)-5-(N-ethylcyclopropanecarboxamido)-4-methyl-4′-morpholino-[1,1′-biphenyl]-3-c2238820-26-1C32H38N4O4
Rel-5-(4-Chloro-2-fluorophenyl)-2,3-dimethyl-7-[(2R,4S)-tetrahydro-2-(1-methyl-1H-pyrazol-4-yl)-2H-pyran-4-yl]pyrido[3,4-b]pyrazine2738485-99-7C24H23ClFN5O
2,5-Morpholinedione, 4-methyl-6-(1-methylethyl)-3-(phenylmethyl)-2180287-51-6C15H19NO3
4-(2-chloro-4-methoxy-5-methylphenyl)-N-[(1A)-2-cyclopropyl-1-(3-fluoro-4-methylphenyl)ethyl]-5-methyl-N-(2-propyn-1-yl)-2-thiazolam2649012-21-3C27H28ClFN2OS
(4S,5R)-3-tert-butoxycarbony-2-(4-anisy)-4-phenyl-5-oxazolidinecarboxylic acid, 10 mM in DMSO(4S,5R)-3-(TERT-ブチルトキシカルボニル)-2-(4-メトキシフェニル)-4-フェニルオキサゾリジン-5-カルボン酸196404-55-4C22H25NO6
IHMT-PI3Kδ-372 S-isomer, 10 mM in DMSO2429889-61-0C26H23F2N7O2
4-benzyloxycarbonylamino-piperidine-1,4-dicarboxylic acid mono-tert-butyl ester, 10 mM in DMSO4-[(ベンジルオキシカルボニル)アミノ]ピペリジン-1,4-ジカルボン酸1-tert-ブチル288154-16-5C19H26N2O6
SOD1-Derlin-1 inhibitor 56-59, 10 mM in DMSO2170170-27-9C22H18N4OS
(1S,2R)-Alicapistat, 10 mM in DMSO2221010-57-5C25H27N3O4
Benzyl-piperazine-CO-benzothiazole-4-methylpiperidine, 10 mM in DMSO906258-48-8C25H30N4OS
(2S)-4-biphenyl-4-yl-N-hydroxy-2-methyl-2-(methylsulfonyl)butanamide, 10 mM in DMSO1354546-42-1C18H21NO4S
1H-Pyrrolo[2,1-c][1,2,4]benzothiadiazine, 2,3,3a,4-tetrahydro-, 5,5-dioxide, (3aR)-, 10 mM in DMSO175340-21-3C10H12N2O2S
N-[2-nitro-4-(trifluoromethyl)phenyl]piperazine, 10 mM in DMSO1-(2-ニトロ-4-トリフルオロメチルフェニル)ピペラジン58315-38-1C11H12F3N3O2
W140 HBr, 10 mM in DMSO1246817-25-3C16H27N2O4P
1-(4-chloro-3-(trifluoromethyl)phenyl)-3-(7-(1-methyl-1H-pyrazol-4-yl)-2,3,4,9-tetrahydro-1H-carbazol-3-yl)urea, 10 mM in DMSO2379727-88-3C24H21ClF3N5O
MMRi62, 10 mM in DMSO352693-80-2C21H15Cl2N3O
T6167923, 10 mM in DMSO2437475-16-4C17H20BrN3O3S2
SOD1-Derlin-1 inhibitor-1840461-03-2C19H12Br2N4OS
Compound STK672155, 10 mM in DMSO339284-01-4C27H21ClN2O7S
4-(9H-fluoren-9-ylmethoxycarbonylamino)-piperidine-1,4-dicarboxylic acid mono-tert-butyl ester, 10 mM in DMSON-BOC-アミノ-(4-N-FMOC-ピペリジニル)カルボン酸183673-66-7C26H30N2O6
3-(2,6-dichlorobenzyl)-1-hexadecyl-2-methyl-1H-imidazol-3-ium iodide
EM-651, 10 mM in DMSO182167-58-4C29 H31 N O4
3-(2,6-dichlorobenzyl)-1-hexadecyl-2-methyl-1H-imidazol-3-ium iodide, 10 mM in DMSO
1H-Pyrazole-5-carboxamide, 4-(5-chloro-2-furanyl)-1,3-bis(2,4-difluorophenyl)-4,5-dihydro-5-methyl-N-[(4-methyl-2-morpholinyl)methyl2171015-78-2C27H25ClF4N4O3
Fmoc-Cys(Acm)-OH, 10 mM in DMSOFMOC-CYS(ACM)-OH86060-81-3C21H22N2O5S
(2S,3S)-3-Hydroxy-2-methyl-3-phenylpropanoic acid(2S,3S)-2-メチル-3-ヒドロキシ-3-フェニルプロピオン酸76549-02-5C10H12O3
Z-Asp(OBzl)-OH, 10 mM in DMSON-[(ベンジルオキシ)カルボニル]-L-アスパラギン酸4-ベンジル3479-47-8C19H19NO6
Benzo[b]thiophene-7-propanoic acid, α-methoxy-4-[2-(5-methyl-2-phenyl-4-oxazolyl)ethoxy]-, (αR)-, 10 mM in DMSO849150-59-0C24H23NO5S
T863, 10 mM in DMSO701232-20-4C22H26N4O3
1H-Indole, 3,3''-(2-thienylmethylene)bis[2-methyl-138801-72-6C23H20N2S
Protease-Activated Receptor-4 diTFA, 10 mM in DMSO
2-((9R,10S,11R,15S)-12,14-dioxo-9,10-dih, 10 mM in DMSO475100-30-2C24H23NO4
Fmoc-His-OHNα-(9H-フルオレン-9-イルメトキシカルボニル)-L-ヒスチジン116611-64-4C21H19N3O4
N-terminally acetylated Leu-enkephalin
CY5-SE triethylamine salt1497420-70-8C43H58N4O10S2
(2R,3S,11bS)-9,10-dimethoxy-3-(2-methylpropyl)-1H,2H,3H,4H,6H,7H,11bH-pyrido[2,1-a]isoquinolin-2-ol924854-62-6C19H29NO3
(1R,5S,6r)-N-(2-methyl-1-((3-methylpyridin-2-yl)oxy)propan-2-yl)-3-azabicyclo[3.1.0]hexane-6-carboxamide L(+)-Tartaric acid2919211-45-1C16H23N3O2.C4H6O6
4-(4-Amino-3-fluorophenoxy)-N-methylpicolinamide4-(4-アミノ-3-フルオロフェノキシ)-N-メチル-2-ピリジンカルボキサミド757251-39-1C13H12FN3O2
N-(1-benzyl-4-piperidyl)adamantane-1-carboxamide, 10 mM in DMSO314030-54-1C23H32N2O
Thyrotropin-Releasing Hormone (TRH), Free Acid, 10 mM in DMSOチロトロピン放出ホルモン, 遊離酸24769-58-2C16H21N5O5
4-Pyridinecarboxaldehyde, 2-(2-pyridinyl)hydrazone, [C(E)]-2241017-37-6C11H10N4
Thalidomide-O-amido-PEG3-C2-NH2 TFA1957236-21-3C25H31F3N4O11
2,3-dihydro-1H-indene-5-sulfonamide, 10 mM in DMSO2,3-ジヒドロ-1H-インデン-5-スルホンアミド35203-93-1C9H11NO2S
sodium lauroyl-α-hydroxyethyl sulfonate
8-(4-iodophenyl)-1,3,5,7-tetramethyl BODIPY[1-[(3,5-ジメチル-1H-ピロール-2-イル)(3,5-ジメチル-2H-ピロール-2-イリデン)メチル]-4-ヨードベンゼン](ジフルオロボラン)250734-47-5C19H19BF2IN2
3-Morpholino-1-(4-(2-oxopiperidin-1-yl)phenyl)-5,6-dihydropyridin-2(1H)-one3-モルホリノ-1-(4-(2-オキソピペリジン-1-イル)フェニル)-5,6-ジヒドロピリジン-2(1H)-オン545445-44-1C20H25N3O3
N4-benzyl-N2-methylquinazoline-2,4-diamine hydrochloride, 10 mM in DMSO1135272-09-1C16H17ClN4
Xanthine oxidoreductase-IN-51026652-90-3C17H17N5O2
cis-1-(3-Chloroallyl)-3,5,7-triaza-1-azoniaadamantane chlorideクォーターニウム-1551229-78-8C9H16Cl2N4
Fmoc-L-glutamic acid 5-tert-butyl esterN-[(9H-フルオレン-9-イルメトキシ)カルボニル]-L-グルタミン酸5-tert-ブチル水和物71989-18-9C24H27NO6
H-Asp(OtBu)-OtBu HClL-アスパラギン酸ジ-TERT-ブチルエステル塩酸塩1791-13-5C12H24ClNO4
(R)-Naroparcil252647-51-1
(S)-3-AMino-2-Methylpropanoic acid-HCl, 10 mM in DMSO(S)-3-アミノ-2-メチルプロパン酸塩酸塩925704-45-6C4H10ClNO2
Methyl retinoateレチン酸メチル339-16-2C21H30O2
Phos-tag Acrylamide AAL-107871839-54-2C33H38N8O3
1-[(5-methylisoxazol-3-yl)methyl]piperazine, 10 mM in DMSO173850-51-6C9H15N3O
A2B receptor antagonist 2 hydrochloride724-70-9C12H15N5.ClH
BDCRB1-β-D-リボフラノシル-2-ブロモ-5,6-ジクロロ-1H-ベンゾイミダゾール142356-43-2C12H11BrCl2N2O4
Thrombin Receptor Activator for Peptide
Bz-RS-ISer(3-Ph)-Ome, 10 mM in DMSOBENZYLOXYPHENYLISOSERINE METHYLESTER,N- (TAXOL SIDE CHAIN METHYLESTER)32981-85-4C17H17NO4
T807, 10 mM in DMSO1415379-56-4C16H10FN3
6-Phenyldihydropyrimidine-2,4(1h,3h)-dione, 10 mM in DMSO6300-95-4C10H10N2O2
LSKL, Inhibitor of Thrombospondin TSP-1 acetate
DDG-39, 10 mM in DMSO1-(2-フルオロ-2,3-ジデオキシ-β-D-アラビノフラノシル)シトシン119555-47-4C9H12FN3O3
Protease-Activated Receptor-4 diTFA
(6Z)-7-Phenyl-7-(3-Pyridinyl)-6-Heptenoic Acid89667-39-0C18H19NO2
3-Phenyl-N-[1-(phenylmethyl)-4-piperidinyl]-tricyclo[3.3.1.13,7]decane-1-carboxamide, 10 mM in DMSO1252187-41-9C29H36N2O
Datelliptium chloride hydrochloride157000-76-5C23H28ClN3O
COH-SR4, 10 mM in DMSO73439-19-7C13H8Cl4N2O
N′-(2-Chloroethyl)-N-(4-methylcyclohexyl)-N-nitrosourea75219-93-1C10H18ClN3O2
Adrenocorticotropic Hormone (ACTH) (4-10) TFA
6''-hydroxydihydrocinchonidine5962-19-6C19H24N2O2
ZY-19489, 10 mM in DMSO1821293-40-6C24H32FN9
2-benzylsulfanyl-6-methoxy-4-methylquinazoline, 10 mM in DMSO500272-00-4C17H16N2OS
2-CHLOROMETHYL-1,1-DIOXO-1,2-DIHYDRO-1LAMBDA*6*-BENZO[D]ISOTHIAZOL-3-ONE, 10 mM in DMSO13947-21-2C8H6ClNO3S
1-(4-AMinophenyl)-5,6-dihydro-3-(4-Morpholinyl)-2(1h)-pyridinone1-(4-アミノフェニル)-3-モルホリノ-5,6-ジヒドロピリジン-2(1H)-オン1267610-26-3C15H19N3O2
Nav1.8-IN-1, 10 mM in DMSO1026822-49-0C20H15ClF3N3O2
CS-B16281434643-33-0C15H19BrN2O4S
Adrenocorticotropic Hormone (ACTH) (4-10) TFA, 10 mM in DMSO
2-(2-fluoro-6-methoxyphenyl)pyrimidine-4-carboxylic acid1502645-66-0C12H9FN2O3
EOB-DTPA158599-72-5C23H33N3O11
N-[3,5-bis(trifluoroMethyl)phenyl]-N''-[(9R)-6''-Methoxycinchonan-9-yl]- Thiourea, 10 mM in DMSO1-(3,5-ビス(トリフルオロメチル)フェニル)-3-((1R)-(6-メトキシキノリン-4-イル)((2R,4S,5R)-5-ビニルキヌクリジン-2-イル)メチル)チオ尿素852913-25-8C29H28F6N4OS
1-(2-fluorophenyl)-3-[5-(2-methoxyphenyl)-1,3,4-thiadiazol-2-yl]urea426242-86-6C16H13FN4O2S
Thalidomide-O-amido-C4-NH2 TFA, 10 mM in DMSO1799711-25-3C21H23F3N4O8
((3S,5R)-5-((1H-1,2,4-Triazol-1-yl)methyl)-5-(2,4-difluorophenyl)tetrahydrofuran-3-yl)methyl 4-methylbenzenesulfonatep-トルエンスルホン酸(3S,5R)-5-(2,4-ジフルオロフェニル)-5-[(1H-1,2,4-トリアゾール-1-イル)メチル]オキソラン-3-イルメチル149809-43-8C21H21F2N3O4S
Phenol, 2-methoxy-5-[(1Z)-2-(3,4,5-trimethoxyphenyl)ethenyl]-, 1,1''-(hydrogen phosphate)735261-22-0C36H39O12P
MOG peptide (35-55) , mouse, rat acetate
Anisole-piperazine-methanone-benzothiazole-p-methylpiperidine, 10 mM in DMSO906258-69-3C25H30N4O2S
6-[(3S,8S,9S,10R,13S,14S,17S)-3-hydroxy-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl]-1314134-92-3C26H31N3O2
Cis-5-Norbornene-exo-2,3-dicarboxylic Anhydridecis-5-ノルボルネン-exo-2,3-ジカルボン酸無水物2746-19-2C9H8O3
2,4-Dioxaspiro(5.5)undec-8-ene, 3-(2-furanyl)-, 10 mM in DMSO80499-32-7C13H16O3
(2-{[2-(2-fluorophenoxy)ethyl]sulfanyl}-1H-benzimidazol-1-yl)acetic acid303134-93-2C17H15FN2O3S
1-benzyl-2-ethyl-4,5,6,7-tetrahydro-1H-indol-4-one, 10 mM in DMSO218934-50-0C17H19NO
2,3-BIS(N-BUTYLTHIO)-1,4-NAPHTHALENEDION2,3-ビス(N-ブチルチオ)-1,4-ナフタレンジオン671189-54-1C18H22O2S2
LSKL, Inhibitor of Thrombospondin TSP-1 acetate, 10 mM in DMSO
2-chloro-5-(16,18-dioxo-17-azapentacyclo[6.6.5.0~2,7~.0~9,14~.0~15,19~]nonadeca-2,4,6,9,11,13-hexaen-17-yl)benzoic acid, 10 mM in DM327033-56-7C25H16ClNO4
Ethyl 1-(4-methoxyphenyl)-7-oxo-6-(4-(2-oxopiperidin-1-yl)phenyl)-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine-3-carboxylate1-(4-メトキシフェニル)-7-オキソ-6-(4-(2-オキソピペリジン-1-イル)フェニル)-4,5,6,7-テトラヒドロ-1H-ピラゾロ[3,4-C]ピリジン-3-カルボン酸エチル503614-91-3C27H28N4O5
1H-Benzimidazole-6-carboxamide, N-[3-(aminocarbonyl)-4,5,6,7-tetrahydrobenzo[b]thien-2-yl]-941185-83-7C17H16N4O2S
3,7-dimethylocta-2,6-dienyl 5,9,13-trimethyltetradeca-4,8,12-enoate, 10 mM in DMSO5,9,13-トリメチル-4,8,12-テトラデカトリエン酸3,7-ジメチル-2,6-オクタジエニル16898-88-7C27H44O2
2-(2-bromophenyl)-5-chloro-4H-3,1-benzoxazin-4-one, 10 mM in DMSO1234707-32-4C14H7BrClNO2
213 214 215 216 217 218 219 220 221 222 223 224 225 226 227 228 229 230 231 232 233 234 235 236 237 238 239 240 241 242 243 244 245 246 247 248 249 250 251 252 253 254 255 256 257 258 259 260 261 262 263 264 265 266 267 268 269 270 271 272 273 274 275 276 277 278 279 280 281 282 283 284 285 286 287 288 289 290 291 292 293 294 295 296 297 298 299 300 301 302 303 304 305 306 307 308 309 310 311 312 313 314 315 316 317
Copyright 2017 ? ChemicalBook. All rights reserved